Summary

Global Antibody Drug Conjugates Market 2024-2028
The antibody drug conjugates market is forecasted to grow by USD 9.95 bn during 2023-2028, accelerating at a CAGR of 15.06% during the forecast period. The report on the antibody drug conjugates market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer and other diseases, technological advancements in ADC development, and increasing investments in pharmaceutical research and development.
Technavio's antibody drug conjugates market is segmented as below:
By Application
• Breast cancer
• Blood cancer
• Others
By Technology
• Cleavable linker
• Non-cleavable linker
• Linkerless
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the increasing adoption and development of targeted therapies as one of the prime reasons driving the antibody drug conjugates market growth during the next few years. Also, advancements in technology and manufacturing processes and increasing demand for personalized medicine in cancer treatment will lead to sizable demand in the market.
The report on the antibody drug conjugates market covers the following areas:
• Antibody drug conjugates market sizing
• Antibody drug conjugates market forecast
• Antibody drug conjugates market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibody drug conjugates market vendors that include AbbVie Inc., Adcendo ApS, Araris Biotech AG, Astellas Pharma Inc., AstraZeneca Plc, Daiichi Sankyo Co. Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., ImmunoGen Inc., Merck KGaA, Mersana Therapeutics Inc., Mythic Therapeutics, Pfizer Inc., Piramal Enterprises Ltd., PPF Group, Regeneron Pharmaceuticals Inc., Seagen Inc., Syngene International Ltd., Takeda Pharmaceutical Co. Ltd., and ADC Therapeutics SA. Also, the antibody drug conjugates market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/antibody-drug-conjugates-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global antibody drug conjugates market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global antibody drug conjugates market 2018 - 2022 ($ billion)
o 4.2 Application Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
o 4.3 Technnology Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Technnology Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Breast cancer - Market size and forecast 2023-2028
o Exhibit 34: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
o 6.4 Blood cancer - Market size and forecast 2023-2028
o Exhibit 38: Chart on Blood cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Blood cancer - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
o 6.5 Others - Market size and forecast 2023-2028
o Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Application
o Exhibit 46: Market opportunity by Application ($ billion)
o Exhibit 47: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 48: Chart on Technology - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Technology - Market share 2023-2028 (%)
o 7.2 Comparison by Technology
o Exhibit 50: Chart on Comparison by Technology
o Exhibit 51: Data Table on Comparison by Technology
o 7.3 Cleavable linker - Market size and forecast 2023-2028
o Exhibit 52: Chart on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
o 7.4 Non-cleavable linker - Market size and forecast 2023-2028
o Exhibit 56: Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
o 7.5 Linkerless - Market size and forecast 2023-2028
o Exhibit 60: Chart on Linkerless - Market size and forecast 2023-2028 ($ billion)
o Exhibit 61: Data Table on Linkerless - Market size and forecast 2023-2028 ($ billion)
o Exhibit 62: Chart on Linkerless - Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Technology
o Exhibit 64: Market opportunity by Technology ($ billion)
o Exhibit 65: Data Table on Market opportunity by Technology ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share by geography 2023-2028 (%)
o Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
o Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 107: Market opportunity by geography ($ billion)
o Exhibit 108: Data Tables on Market opportunity by geography ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 115: AbbVie Inc. - Overview
o Exhibit 116: AbbVie Inc. - Product / Service
o Exhibit 117: AbbVie Inc. - Key news
o Exhibit 118: AbbVie Inc. - Key offerings
o 12.4 ADC Therapeutics SA
o Exhibit 119: ADC Therapeutics SA - Overview
o Exhibit 120: ADC Therapeutics SA - Product / Service
o Exhibit 121: ADC Therapeutics SA - Key offerings
o 12.5 Astellas Pharma Inc.
o Exhibit 122: Astellas Pharma Inc. - Overview
o Exhibit 123: Astellas Pharma Inc. - Product / Service
o Exhibit 124: Astellas Pharma Inc. - Key news
o Exhibit 125: Astellas Pharma Inc. - Key offerings
o 12.6 AstraZeneca Plc
o Exhibit 126: AstraZeneca Plc - Overview
o Exhibit 127: AstraZeneca Plc - Product / Service
o Exhibit 128: AstraZeneca Plc - Key news
o Exhibit 129: AstraZeneca Plc - Key offerings
o 12.7 Daiichi Sankyo Co. Ltd.
o Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 Gilead Sciences Inc.
o Exhibit 139: Gilead Sciences Inc. - Overview
o Exhibit 140: Gilead Sciences Inc. - Product / Service
o Exhibit 141: Gilead Sciences Inc. - Key news
o Exhibit 142: Gilead Sciences Inc. - Key offerings
o 12.10 ImmunoGen Inc.
o Exhibit 143: ImmunoGen Inc. - Overview
o Exhibit 144: ImmunoGen Inc. - Product / Service
o Exhibit 145: ImmunoGen Inc. - Key offerings
o 12.11 Merck KGaA
o Exhibit 146: Merck KGaA - Overview
o Exhibit 147: Merck KGaA - Business segments
o Exhibit 148: Merck KGaA - Key news
o Exhibit 149: Merck KGaA - Key offerings
o Exhibit 150: Merck KGaA - Segment focus
o 12.12 Mersana Therapeutics Inc.
o Exhibit 151: Mersana Therapeutics Inc. - Overview
o Exhibit 152: Mersana Therapeutics Inc. - Product / Service
o Exhibit 153: Mersana Therapeutics Inc. - Key offerings
o 12.13 Pfizer Inc.
o Exhibit 154: Pfizer Inc. - Overview
o Exhibit 155: Pfizer Inc. - Product / Service
o Exhibit 156: Pfizer Inc. - Key news
o Exhibit 157: Pfizer Inc. - Key offerings
o 12.14 Regeneron Pharmaceuticals Inc.
o Exhibit 158: Regeneron Pharmaceuticals Inc. - Overview
o Exhibit 159: Regeneron Pharmaceuticals Inc. - Product / Service
o Exhibit 160: Regeneron Pharmaceuticals Inc. - Key offerings
o 12.15 Seagen Inc.
o Exhibit 161: Seagen Inc. - Overview
o Exhibit 162: Seagen Inc. - Key offerings
o 12.16 Syngene International Ltd.
o Exhibit 163: Syngene International Ltd. - Overview
o Exhibit 164: Syngene International Ltd. - Product / Service
o Exhibit 165: Syngene International Ltd. - Key offerings
o 12.17 Takeda Pharmaceutical Co. Ltd.
o Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 170: Inclusions checklist
o Exhibit 171: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 172: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 173: Research methodology
o Exhibit 174: Validation techniques employed for market sizing
o Exhibit 175: Information sources
o 13.5 List of abbreviations
o Exhibit 176: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global antibody drug conjugates market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Technnology Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Data Table on Market opportunity by Application ($ billion)
Exhibits48: Chart on Technology - Market share 2023-2028 (%)
Exhibits49: Data Table on Technology - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Technology
Exhibits51: Data Table on Comparison by Technology
Exhibits52: Chart on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Technology ($ billion)
Exhibits65: Data Table on Market opportunity by Technology ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2023-2028 (%)
Exhibits68: Data Table on Market share by geography 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity by geography ($ billion)
Exhibits108: Data Tables on Market opportunity by geography ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: ADC Therapeutics SA - Overview
Exhibits120: ADC Therapeutics SA - Product / Service
Exhibits121: ADC Therapeutics SA - Key offerings
Exhibits122: Astellas Pharma Inc. - Overview
Exhibits123: Astellas Pharma Inc. - Product / Service
Exhibits124: Astellas Pharma Inc. - Key news
Exhibits125: Astellas Pharma Inc. - Key offerings
Exhibits126: AstraZeneca Plc - Overview
Exhibits127: AstraZeneca Plc - Product / Service
Exhibits128: AstraZeneca Plc - Key news
Exhibits129: AstraZeneca Plc - Key offerings
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. - Overview
Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits136: F. Hoffmann La Roche Ltd. - Key news
Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits139: Gilead Sciences Inc. - Overview
Exhibits140: Gilead Sciences Inc. - Product / Service
Exhibits141: Gilead Sciences Inc. - Key news
Exhibits142: Gilead Sciences Inc. - Key offerings
Exhibits143: ImmunoGen Inc. - Overview
Exhibits144: ImmunoGen Inc. - Product / Service
Exhibits145: ImmunoGen Inc. - Key offerings
Exhibits146: Merck KGaA - Overview
Exhibits147: Merck KGaA - Business segments
Exhibits148: Merck KGaA - Key news
Exhibits149: Merck KGaA - Key offerings
Exhibits150: Merck KGaA - Segment focus
Exhibits151: Mersana Therapeutics Inc. - Overview
Exhibits152: Mersana Therapeutics Inc. - Product / Service
Exhibits153: Mersana Therapeutics Inc. - Key offerings
Exhibits154: Pfizer Inc. - Overview
Exhibits155: Pfizer Inc. - Product / Service
Exhibits156: Pfizer Inc. - Key news
Exhibits157: Pfizer Inc. - Key offerings
Exhibits158: Regeneron Pharmaceuticals Inc. - Overview
Exhibits159: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits160: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits161: Seagen Inc. - Overview
Exhibits162: Seagen Inc. - Key offerings
Exhibits163: Syngene International Ltd. - Overview
Exhibits164: Syngene International Ltd. - Product / Service
Exhibits165: Syngene International Ltd. - Key offerings
Exhibits166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits169: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations